BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maverakis E, Marzano AV, Le ST, Callen JP, Brüggen M, Guenova E, Dissemond J, Shinkai K, Langan SM. Pyoderma gangrenosum. Nat Rev Dis Primers 2020;6. [DOI: 10.1038/s41572-020-0213-x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 24.5] [Reference Citation Analysis]
Number Citing Articles
1 Bordeaux ZA, Kwatra SG, West CE. Treatment of pyoderma gangrenosum with apremilast monotherapy. JAAD Case Reports 2022;30:8-10. [DOI: 10.1016/j.jdcr.2022.10.001] [Reference Citation Analysis]
2 Kim Y, Shim HS, Jeong H, Park Y. Pyoderma Gangrenosum Triggered by COVID-19 Vaccination in a Patient with Ulcerative Colitis: A Case Report. The International Journal of Lower Extremity Wounds 2022. [DOI: 10.1177/15347346221141173] [Reference Citation Analysis]
3 Nishimura M, Mizutani K, Yokota N, Goto H, Akeda T, Kitagawa H, Habe K, Hayashi A, Yamanaka K. Treatment Strategy for Pyoderma Gangrenosum: Skin Grafting with Immunosuppressive Drugs. JCM 2022;11:6924. [DOI: 10.3390/jcm11236924] [Reference Citation Analysis]
4 Oganesyan A, Gregory A, Malard F, Ghahramanyan N, Mohty M, Kazandjian D, Mekinian A, Hakobyan Y. Monoclonal gammopathies of clinical significance (MGCS): In pursuit of optimal treatment. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1045002] [Reference Citation Analysis]
5 Huynh J, Aronowitz P. Pyoderma Gangrenosum Secondary to Herpes Zoster. AIM Clinical Cases 2022;1. [DOI: 10.7326/aimcc.2022.0841] [Reference Citation Analysis]
6 Wasiak M, Ciszek M, Babiak I, Wasilewski P, Łęgosz P, Kieroński B, Małdyk P. An aggressive course of pyoderma gangrenosum mimicking bacterial osteomyelitis after open reduction and internal fixation of a distal radius fracture with a titanium plate. Reumatologia 2022;60:292-302. [PMID: 36186837 DOI: 10.5114/reum.2022.119046] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Chu Y, Liu T, Bai J, Fang H, Qiao J. Successful Treatment of a Patient with Pyoderma Gangrenosum, Plaque Psoriasis and Palmoplantar Pustulosis with Adalimumab. Clin Cosmet Investig Dermatol 2022;15:1991-5. [PMID: 36164556 DOI: 10.2147/CCID.S373115] [Reference Citation Analysis]
8 Sitaru S, Biedermann T, Lauffer F. Successful treatment of pyoderma gangrenosum with Janus kinase 1/2 inhibition. JEADV Clinical Practice 2022. [DOI: 10.1002/jvc2.62] [Reference Citation Analysis]
9 Mulholland O, Middleton D, Hunter H. Negative-pressure wound therapy as an adjunct to treating pyoderma gangrenosum. Journal of the Royal College of Physicians of Edinburgh. [DOI: 10.1177/14782715221126768] [Reference Citation Analysis]
10 Wu J, Chen L, Dang F, Zha P, Li R, Ran X. Refractory wounds induced by normal-renal calciphylaxis: An under-recognised calcific arteriolopathy. Int Wound J 2022. [PMID: 36068658 DOI: 10.1111/iwj.13951] [Reference Citation Analysis]
11 Doshi S, Lee Y. Pyoderma Gangrenosum Mimicking Necrotizing Fasciitis in a Marathon Runner With Myelodysplastic Syndrome. AIM Clinical Cases 2022;1. [DOI: 10.7326/aimcc.2022.0240] [Reference Citation Analysis]
12 Polyakova IN, Miroshnichenko AP, Aleksandrova MI, Stryuk RI. Aseptic nasal septal abscess in patients with ulcerative colitis: two case reports. Case report. Terapevticheskii arkhiv 2022;94:884-890. [DOI: 10.26442/00403660.2022.07.201736] [Reference Citation Analysis]
13 Teplyuk NP, Grabovskaya OV, Kusraeva DT, Varshavsky VA. Pyoderma gangrenosum: examination and treatment experience. Russian Journal of Skin and Venereal Diseases 2022;25:61-72. [DOI: 10.17816/dv105685] [Reference Citation Analysis]
14 Burlage E, Mulder JWCM, Nellensteijn JM, Zeegers AVCM. Infection mimicking skin condition: pyoderma gangrenosum. BMJ Case Rep 2022;15:e247770. [DOI: 10.1136/bcr-2021-247770] [Reference Citation Analysis]
15 Shah N, Asdourian MS, Jacoby TV, Chen ST. Neutrophilic Dermatosis and Management Strategies for the Inpatient Dermatologist. Curr Derm Rep. [DOI: 10.1007/s13671-022-00364-7] [Reference Citation Analysis]
16 Jones JM, Bastick JC, Schadt CR. Clinical Challenge in Urology: A Nonhealing Wound on the Glans Penis. Urology 2022:S0090-4295(22)00591-X. [PMID: 35843355 DOI: 10.1016/j.urology.2022.07.001] [Reference Citation Analysis]
17 Sakkab R, Fabrikant JM. Leukocytoclastic Vasculitis of the Foot and Ankle: A Case Report With Over Five-Year Follow-Up. Cureus 2022. [DOI: 10.7759/cureus.25371] [Reference Citation Analysis]
18 Michel D, Dege T, Kneitz H, Stumpf M, Goebeler M, Schmieder A. Pyoderma gangraenosum als diagnostische und therapeutische interdisziplinäre Herausforderung. Aktuelle Rheumatologie. [DOI: 10.1055/a-1798-5164] [Reference Citation Analysis]
19 Maronese CA, Pimentel MA, Li MM, Genovese G, Ortega-Loayza AG, Marzano AV. Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments. Am J Clin Dermatol 2022. [PMID: 35606650 DOI: 10.1007/s40257-022-00699-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Xue Y, Zhou J, Xu BN, Li Y, Bao W, Cheng XL, He Y, Xu CP, Ren J, Zheng YR, Jia CY. Global Burden of Bacterial Skin Diseases: A Systematic Analysis Combined With Sociodemographic Index, 1990-2019. Front Med (Lausanne) 2022;9:861115. [PMID: 35547219 DOI: 10.3389/fmed.2022.861115] [Reference Citation Analysis]
21 Dissemond J, Romanelli M. Inflammatory skin diseases and wounds. Br J Dermatol 2022. [PMID: 35514247 DOI: 10.1111/bjd.21619] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Evangelatos G, Bamias G, Kitas GD, Kollias G, Sfikakis PP. The second decade of anti-TNF-a therapy in clinical practice: new lessons and future directions in the COVID-19 era. Rheumatol Int 2022. [PMID: 35503130 DOI: 10.1007/s00296-022-05136-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Čubrić E, Šupe M, Krečak I. Persistent fever, bloody diarrhea, and skin necrosis in a young female. European Journal of Internal Medicine 2022. [DOI: 10.1016/j.ejim.2022.05.008] [Reference Citation Analysis]
24 Pagani K, Lukac D, Bhukhan A, McGee JS. Cutaneous Manifestations of Inflammatory Bowel Disease: A Basic Overview. Am J Clin Dermatol 2022. [PMID: 35441942 DOI: 10.1007/s40257-022-00689-w] [Reference Citation Analysis]
25 Claveau JS, Wetter DA, Kumar S. Cutaneous manifestations of monoclonal gammopathy. Blood Cancer J 2022;12:58. [PMID: 35411042 DOI: 10.1038/s41408-022-00661-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
26 Wang Y, Wan Z, Jin R, Xu T, Ouyang Y, Wang B, Ruan G, Bai X. Tofacitinib for extraintestinal manifestations of inflammatory bowel disease: A literature review. International Immunopharmacology 2022;105:108517. [DOI: 10.1016/j.intimp.2022.108517] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Huang J, Tsang LS, Shi W, Li J. Pyoderma Gangrenosum, Acne, and Hidradenitis Suppurativa Syndrome: A Case Report and Literature Review. Front Med 2022;9:856786. [DOI: 10.3389/fmed.2022.856786] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Weiss EH, Ko CJ, Leung TH, Micheletti RG, Mostaghimi A, Ramachandran SM, Rosenbach M, Nelson CA. Neutrophilic Dermatoses: a Clinical Update. Curr Derm Rep. [DOI: 10.1007/s13671-022-00355-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Sondermann W, Fischer L, Hadaschik E, Dissemond J. Exacerbated Psoriasis as a Rare Trigger of Multilocular Pyoderma Gangrenosum: A Case Report of a Rare Coincidence. The International Journal of Lower Extremity Wounds. [DOI: 10.1177/1534734621990297] [Reference Citation Analysis]
30 Rao S, Tang Y, Li J, Shi W. A rapidly progressing, painful ulcer at a surgical wound site. BMJ 2022;376:e068211. [PMID: 35172990 DOI: 10.1136/bmj-2021-068211] [Reference Citation Analysis]
31 Guimaraens BD, Valle AS, Domínguez-santás M, Corralo DS. Protocolo diagnóstico de las lesiones ulceradas. Medicine - Programa de Formación Médica Continuada Acreditado 2022;13:2830-2835. [DOI: 10.1016/j.med.2022.02.007] [Reference Citation Analysis]
32 Dissemond J, Bültemann A, Gerber V, Motzkus M, Münter KC, Erfurt-berge C. Positionspapier der Initiative Chronische Wunde (ICW) e. V. zur Nomenklatur des Débridements chronischer Wunden. Hautarzt. [DOI: 10.1007/s00105-022-04944-3] [Reference Citation Analysis]
33 Barry M, AlRajhi A, Aljerian K. Pyoderma Gangrenosum Induced by BNT162b2 COVID-19 Vaccine in a Healthy Adult. Vaccines (Basel) 2022;10:87. [PMID: 35062748 DOI: 10.3390/vaccines10010087] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
34 Ilyas F. Successful low-dose corticosteroid treatment of aggressive pyoderma gangrenosum with irritable bowel syndrome: a case report. Acta Dermatovenerologica Alpina Pannonica et Adriatica 2022;31. [DOI: 10.15570/actaapa.2022.17] [Reference Citation Analysis]
35 Teplyuk NP, Grabovskaya OV, Kusraeva DT, Grekova EV, Varshavsky VA. Ulcers of Lower Extremities. Clinical Cases in Geriatric Exfoliative Dermatitis 2022. [DOI: 10.1007/978-3-031-09436-1_24] [Reference Citation Analysis]
36 Ni X, Lai Y. Crosstalk between keratinocytes and immune cells in inflammatory skin diseases. Explor Immunol 2021. [DOI: 10.37349/ei.2021.00028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
37 Summa S, Hofmann G, Erfurt-berge C. Stomaversorgung bei Pyoderma gangraenosum. coloproctology 2022;44:42-6. [DOI: 10.1007/s00053-021-00580-y] [Reference Citation Analysis]
38 Klingelhöller C, Schneider SW. Differentialdiagnose Ulcus cruris, Ursachen und Therapie. Phlebologie 2022;51:31-6. [DOI: 10.1055/a-1584-5841] [Reference Citation Analysis]
39 Alvarez-Payares JC, Ramírez-Urrea S, Correa-Parra L, Salazar-Uribe D, Velásquez-López M. Mucocutaneous Manifestations of Inflammatory Bowel Disease. Cureus 2021;13:e17191. [PMID: 34548985 DOI: 10.7759/cureus.17191] [Reference Citation Analysis]
40 Ravi M, Trinidad J, Spaccarelli N, Kaffenberger B. The impact of comorbidity identification on outcomes in patients with pyoderma gangrenosum: A retrospective cohort study of previously hospitalized patients. J Am Acad Dermatol 2021:S0190-9622(21)02181-2. [PMID: 34314745 DOI: 10.1016/j.jaad.2021.07.032] [Reference Citation Analysis]
41 Bhadresha S, Connolly A, Galloway J, Walsh S. A noduloulcerative plaque in a patient with rheumatoid arthritis. Clin Exp Dermatol 2021. [PMID: 34263480 DOI: 10.1111/ced.14778] [Reference Citation Analysis]
42 Ruffer N, Krusche M, Holzer MT, Hagel C, Kötter I. [Differential diagnosis of a vasculitic syndrome of the lower limb]. Z Rheumatol 2021. [PMID: 34241690 DOI: 10.1007/s00393-021-01044-w] [Reference Citation Analysis]
43 Boldin BV, Golosnitskiy PY, Bogachev VY, Rodionov SV, Dizengof IM. Martorell’s ulcer: a literature review and own clinical observation. Ambulatornaya khirurgiya 2021;18:55-70. [DOI: 10.21518/1995-1477-2021-18-1-55-70] [Reference Citation Analysis]
44 Croia C, Dini V, Loggini B, Manni E, Romanelli M, Migliorini P. Evaluation of neutrophil extracellular trap deregulated formation in pyoderma gangrenosum. Exp Dermatol 2021;30:1340-4. [PMID: 34057268 DOI: 10.1111/exd.14397] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
45 Beltagy A, Aghamajidi A, Trespidi L, Ossola W, Meroni PL. Biologics During Pregnancy and Breastfeeding Among Women With Rheumatic Diseases: Safety Clinical Evidence on the Road. Front Pharmacol 2021;12:621247. [PMID: 34122062 DOI: 10.3389/fphar.2021.621247] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
46 Antonelli E, Bassotti G, Tramontana M, Hansel K, Stingeni L, Ardizzone S, Genovese G, Marzano AV, Maconi G. Dermatological Manifestations in Inflammatory Bowel Diseases. J Clin Med 2021;10:364. [PMID: 33477990 DOI: 10.3390/jcm10020364] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 15.0] [Reference Citation Analysis]
47 Trejo-acuña JR, Medina-bojórquez A, Ramos-garibay JA, Zárate-flores LM, Santos-ortíz MF. Pioderma gangrenoso asociado a artritis reumatoide. Revista del Centro Dermatológico Pascua 2021;30:148-155. [DOI: 10.35366/103829] [Reference Citation Analysis]
48 Schmidt E. Miscellaneous Disorders with Oral Manifestations. Diseases of the Oral Mucosa 2021. [DOI: 10.1007/978-3-030-82804-2_48] [Reference Citation Analysis]
49 Jacob JS, Cohen PR. Concurrent Scleredema and Pyoderma Gangrenosum: Case Report and Review of Comorbid Conditions. Cureus 2020. [DOI: 10.7759/cureus.12188] [Reference Citation Analysis]